Skip to main content
. 2022 Sep 22;140(12):1378–1389. doi: 10.1182/blood.2021014270

Table 4.

Multivariate analysis: MRD values measured by RQ-PCR in BM as MRD kinetics

TTP
Variables HR 95% CI P value
MIPI intermediate vs low 0.68 (0.241-1.99) .5
MIPI high vs low 0.78 (0.26-2.36) .7
Ki67 ≥30% 2.27 (0.92-5.61) .075
PR after ASCT 4.74 (1.02-21.9) .046
Alternating MRD after ASCT (vs persistently MRD NEG after ASCT, M6 and M12) 5.51 (2.02-15.0) <.001
Persistently MRD POS after ASCT (vs persistently MRD NEG after ASCT, M6 and M12) 6.93 (1.74-27.6) .006

M6, 6 months from transplant; M12, 12 months from transplant; MRD NEG, negative minimal residual disease; MRD POS, positive minimal residual disease; PR, partial response.

78 randomized patients, landmark analysis starting from 12 months from transplant.